American gastroenterological association institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease

Gastroenterology

Volumn 145, Issue 6, 2013, Pages 1459-1463

  Terdiman, Jonathan P ^a   Gruss, Claudia B ^b   Heidelbaugh, Joel J ^c   Sultan, Shahnaz ^d   Falck Ytter, Yngve T ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ProHealth Physicians Inc   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ADALIMUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; INFECTION; LYMPHOMA; MEDICAL SOCIETY; MONOTHERAPY; MYCOSIS; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; RISK BENEFIT ANALYSIS; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUBERCULOSIS;

EID: 84888221077     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.10.047     Document Type: Article

References (2)

1. S. Sultan, Y. Falck-Ytter, and J.M. Inadomi The AGA Institute process for developing clinical practice guidelines part one: grading the evidence Clin Gastroenterol Hepatol 11 2013 329 332
2. T. Dassopoulos, S. Sultan, and Y.T. Falck-Ytter American Gastroenterological Association technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease Gastroenterology 145 2013 1464 1478